tiprankstipranks
Nkarta (NKTX)
NASDAQ:NKTX
US Market
NKTX
Nkarta
RESEARCH TOOLSreports

Nkarta (NKTX) Stock Forecast & Price Target

703 Followers
See the Price Targets and Ratings of:

NKTX Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Nkarta
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NKTX Stock 12 Month Forecast

Average Price Target

$12.50
▲(434.19% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Nkarta in the last 3 months. The average price target is $12.50 with a high forecast of $16.00 and a low forecast of $11.00. The average price target represents a 434.19% change from the last price of $2.34.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","17":"$17","4.25":"$4.25","8.5":"$8.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$12.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$11.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.25,8.5,12.75,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.7,3.723076923076923,4.746153846153847,5.76923076923077,6.792307692307693,7.815384615384616,8.83846153846154,9.861538461538462,10.884615384615387,11.907692307692308,12.930769230769233,13.953846153846154,14.976923076923079,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.7,3.453846153846154,4.207692307692308,4.961538461538462,5.715384615384616,6.469230769230769,7.223076923076924,7.976923076923078,8.730769230769232,9.484615384615385,10.23846153846154,10.992307692307694,11.746153846153849,{"y":12.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.7,3.3384615384615386,3.976923076923077,4.615384615384616,5.253846153846155,5.892307692307693,6.5307692307692315,7.1692307692307695,7.807692307692308,8.446153846153848,9.084615384615386,9.723076923076924,10.361538461538462,{"y":11,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.34,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.75,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.11,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.85,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.16,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$16.00Average Price Target$12.50Lowest Price Target$11.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on NKTX
Salim Syed
Mizuho Securities
Mizuho Securities
$14→$12
Buy
412.82%
Upside
Reiterated
03/31/26
Nkarta price target lowered to $12 from $14 at MizuhoNkarta price target lowered to $12 from $14 at Mizuho
TD Cowen Analyst forecast on NKTX
Yaron Werber
TD Cowen
TD Cowen
―
Buy
―
Reiterated
03/26/26
Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), QT Imaging Holdings (NASDAQ: QTI) and Cardiff Oncology (NASDAQ: CRDF)
Needham Analyst forecast on NKTX
Gil Blum
Needham
Needham
$10→$11
Buy
370.09%
Upside
Reiterated
03/26/26
Analysts Offer Insights on Healthcare Companies: BioCardia (NASDAQ: BCDA) and Nkarta (NASDAQ: NKTX)
Stifel Nicolaus Analyst forecast on NKTX
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
$11
Buy
370.09%
Upside
Reiterated
03/26/26
Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), BioCardia (BCDA)
H.C. Wainwright Analyst forecast on NKTX
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
$16
Buy
583.76%
Upside
Reiterated
03/26/26
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
William Blair Analyst forecast on NKTX
Sami Corwin
William Blair
William Blair
―
Hold
―
Reiterated
11/11/25
Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), BioLife Solutions (NASDAQ: BLFS) and Cardiff Oncology (NASDAQ: CRDF)
Leerink Partners Analyst forecast on NKTX
Daina Graybosch
Leerink Partners
Leerink Partners
$8
Buy
241.88%
Upside
Reiterated
08/13/25
Leerink Partners Remains a Buy on Nkarta (NKTX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on NKTX
Salim Syed
Mizuho Securities
Mizuho Securities
$14→$12
Buy
412.82%
Upside
Reiterated
03/31/26
Nkarta price target lowered to $12 from $14 at MizuhoNkarta price target lowered to $12 from $14 at Mizuho
TD Cowen Analyst forecast on NKTX
Yaron Werber
TD Cowen
TD Cowen
―
Buy
―
Reiterated
03/26/26
Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), QT Imaging Holdings (NASDAQ: QTI) and Cardiff Oncology (NASDAQ: CRDF)
Needham Analyst forecast on NKTX
Gil Blum
Needham
Needham
$10→$11
Buy
370.09%
Upside
Reiterated
03/26/26
Analysts Offer Insights on Healthcare Companies: BioCardia (NASDAQ: BCDA) and Nkarta (NASDAQ: NKTX)
Stifel Nicolaus Analyst forecast on NKTX
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
$11
Buy
370.09%
Upside
Reiterated
03/26/26
Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), BioCardia (BCDA)
H.C. Wainwright Analyst forecast on NKTX
Emily Bodnar
H.C. Wainwright
H.C. Wainwright
$16
Buy
583.76%
Upside
Reiterated
03/26/26
Buy Rating Initiated on NKX019’s Differentiated CAR‑NK Platform and De‑Risked Autoimmune Opportunity Ahead of 2026 Proof‑of‑Concept Data
William Blair Analyst forecast on NKTX
Sami Corwin
William Blair
William Blair
―
Hold
―
Reiterated
11/11/25
Analysts Offer Insights on Healthcare Companies: Nkarta (NASDAQ: NKTX), BioLife Solutions (NASDAQ: BLFS) and Cardiff Oncology (NASDAQ: CRDF)
Leerink Partners Analyst forecast on NKTX
Daina Graybosch
Leerink Partners
Leerink Partners
$8
Buy
241.88%
Upside
Reiterated
08/13/25
Leerink Partners Remains a Buy on Nkarta (NKTX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Nkarta

3 Months
xxx
Success Rate
12/30 ratings generated profit
40%
Average Return
+19.33%
reiterated a xxx
 rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of +19.33% per trade.
1 Year
Emily BodnarH.C. Wainwright
Success Rate
12/26 ratings generated profit
46%
Average Return
-8.20%
reiterated a buy rating 16 days ago
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of -8.20% per trade.
2 Years
xxx
Success Rate
8/26 ratings generated profit
31%
Average Return
-32.04%
reiterated a xxx
 rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of -32.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NKTX Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
9
4
3
0
4
Buy
2
1
1
0
1
Hold
2
2
17
28
32
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
13
7
21
28
38
In the current month, NKTX has received 5 Buy Ratings, 32 Hold Ratings, and 1 Sell Ratings. NKTX average Analyst price target in the past 3 months is 12.50.
Each month's total comprises the sum of three months' worth of ratings.

NKTX Financial Forecast

NKTX Earnings Forecast

Next quarter’s earnings estimate for NKTX is -$0.35 with a range of -$0.42 to -$0.31. The previous quarter’s EPS was -$0.37. NKTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year NKTX has Performed in-line its overall industry.
Next quarter’s earnings estimate for NKTX is -$0.35 with a range of -$0.42 to -$0.31. The previous quarter’s EPS was -$0.37. NKTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year NKTX has Performed in-line its overall industry.
No data currently available

NKTX Sales Forecast

Next quarter’s sales forecast for NKTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NKTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year NKTX has Performed in-line its overall industry.
Next quarter’s sales forecast for NKTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NKTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year NKTX has Performed in-line its overall industry.

NKTX Stock Forecast FAQ

What is NKTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Nkarta’s 12-month average price target is 12.50.
    What is NKTX’s upside potential, based on the analysts’ average price target?
    Nkarta has 434.19% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is NKTX a Buy, Sell or Hold?
          Nkarta has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Nkarta’s price target?
            The average price target for Nkarta is 12.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $16.00 ,the lowest forecast is $11.00. The average price target represents 434.19% Increase from the current price of $2.34.
              What do analysts say about Nkarta?
              Nkarta’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of NKTX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.